Filing Details
- Accession Number:
- 0001179110-20-008903
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-11 18:20:38
- Reporting Period:
- 2020-08-07
- Accepted Time:
- 2020-08-11 18:20:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1680739 | D. Roy Baynes | C/O Natera, Inc 201 Industrial Road, Ste 410 San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-07 | 1,300 | $24.42 | 1,300 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-08-07 | 1,300 | $53.47 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-08-07 | 1,300 | $0.00 | 1,300 | $24.42 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,230 | 2028-09-13 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.35 to $53.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option shares vest over three years. A third of the option shares vested and became exercisable on July 25, 2019 with the remaining shares vesting in 2 equal annual installments thereafter. The initial option will become fully vested and exercisable in the event that the Company is subject to a change in control.